Terumo (OTCMKTS:TRUMY) Shares Gap Up – Should You Buy?

Terumo Corp. (OTCMKTS:TRUMY)’s share price gapped up prior to trading on Monday . The stock had previously closed at $12.18, but opened at $14.04. Terumo shares last traded at $14.4386, with a volume of 24,330 shares trading hands.

Analyst Ratings Changes

TRUMY has been the subject of several research analyst reports. Zacks Research raised Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded Terumo to a “hold” rating in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.

Terumo Price Performance

The business has a 50-day moving average price of $13.08 and a 200 day moving average price of $13.98. The company has a market cap of $21.15 billion, a price-to-earnings ratio of 23.51 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting analysts’ consensus estimates of $0.11. Terumo had a return on equity of 9.35% and a net margin of 12.09%.The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.84 billion. As a group, research analysts expect that Terumo Corp. will post 0.63 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.